Fact CheckerSign in

NCT06743659Recruiting

Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia

Alert-Based Computerized Decision Support for Identification and Management of Patients With Familial Hypercholesterolemia (FH-ALERT Trial)

Source: ClinicalTrials.gov · Last updated 29 Sept 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn if a computer alert can aid clinicians in identifying patients with a genetic type of high cholesterol, called Familial Hypercholesterolemia. The main question it aims to answer is whether the computer alert increases recognition of this high cholesterol disorder.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
450 (estimated)
First submitted
18 Dec 2024
Start date
1 Apr 2025
Primary completion date
30 Mar 2027
Lead sponsor
Brigham and Women's Hospital
NCT number
NCT06743659

What you commit to

  • Study type: Interventional
  • Planned participants: 450
  • From 1 Apr 2025 to the primary completion date, 30 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • a Familial Hypercholesterolemia diagnosis already documented in the EHR medical history, visit history, or problem list

Who the study is looking for

  • ≥ 18 years old
  • seen in the BWH Endocrinology, Cardiovascular Medicine, and Primary Care Clinics
  • Dutch Lipid Clinic Network score of at least 3 points

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Brigham and Women's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.